ACADIA PHARMACEUTICALS (ACAD) Covered Calls

ACADIA PHARMACEUTICALS covered calls ACADIA Pharmaceuticals Inc. is focused on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders.

You can sell covered calls on ACADIA PHARMACEUTICALS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ACAD (prices last updated Fri 4:16 PM ET):

ACADIA PHARMACEUTICALS (ACAD) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
17.69 +0.22 17.40 17.80 1.0M - 2.2B
Covered Calls For ACADIA PHARMACEUTICALS (ACAD)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Jun 15 17.5 0.95 16.85 3.9% 64.7%
Jul 20 18 1.25 16.55 7.6% 48.7%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is developing a portfolio consisting of four advanced product candidates, including pimavanserin, which is in Phase III development for the treatment of Parkinson's disease psychosis. It also has a product candidate in Phase II for chronic pain and a product candidate in Phase I for glaucoma. ACADIA Pharmaceuticals was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.